Insights into Infant Immune Responses and Omicron Subvariants in Taiwan
Research led by the University of Tübingen and partners at Stanford University, Emory University, and the Cincinnati Children's Hospital Medical Center has found that infants and young children have unique and effective immune responses to SARS-CoV-2. The study revealed that infants mount durable antibody responses for up to 300 days, with robust mucosal and systemic immune reactions. These findings suggest the potential for designing vaccine formulations that leverage these innate immune system activation pathways to avoid excessive inflammation.
